Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers
Published on: July 19, 2024
Tissue-Resident Regulatory T Cells Expressing CD83 Maintain Local Homeostasis and Restrict Th2 Responses in Asthma
Anita Heiß1, Susanne Krammer2, Christine Kuhnt1
1Department of Immune Modulation, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
CD83 is crucial for regulatory T cells (Tregs) in lung tissue. Its absence impairs Treg function, worsening asthma by promoting T-helper 2 (Th2) immune responses.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- Non-lymphoid tissue regulatory T cells (NLT-Tregs) maintain tissue health and control inflammation.
- CD83 is identified as a marker for NLT-Tregs, but its specific function in these cells remains unclear.
- Understanding CD83's role is vital for comprehending tissue homeostasis and immune responses in barrier tissues.
Purpose of the Study:
- To investigate the biological significance of CD83 expression in lung-resident Tregs.
- To determine the role of CD83 in steady-state conditions and during asthma pathogenesis.
- To elucidate CD83's impact on T-cell populations and inflammatory responses in the lungs.
Main Methods:
- Generated Treg-specific CD83 knockout (CD83cKO) mice.
- Analyzed lung-resident T-cell populations and cytokine profiles in CD83cKO mice.
- Utilized an asthma model to assess disease progression and T-helper cell responses in CD83cKO mice.
Main Results:
- CD83-deficient lung Tregs showed reduced differentiation but increased activation, leading to uncontrolled T-cell activation.
- CD83cKO mice exhibited accelerated asthma progression, characterized by a Th2-biased immune response.
- CD83cKO Tregs displayed heightened responsiveness to IL-4, impairing the control of naive T-cell differentiation towards Th2 cells.
Conclusions:
- CD83 plays a critical role in regulating Th2 responses mediated by NLT-Tregs.
- The absence of CD83 disrupts lung homeostasis and exacerbates asthma.
- CD83 is a key regulator of inflammatory responses, with potential therapeutic implications for asthma and other inflammatory diseases.
More Related Videos
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...